CGON
Price:
$25.86
Market Cap:
$1.97B
CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette Guerin (BCG) therapy, the current standard-of-care for high-risk NMIBC.
Industry
Biotechnology
IPO Date
Stock Exchange
NASDAQ
Ticker
CGON
According to CG Oncology, Inc. Common stock’s latest financial reports and current stock price. The company's current Current Ratio is 30.97. This represents a change of -16.95% compared to the average of 37.29 of the last 4 quarters.
The mean historical Current Ratio of CG Oncology, Inc. Common stock over the last ten years is 17.06. The current 30.97 Current Ratio has changed 18.06% with respect to the historical average. Over the past ten years (40 quarters), CGON's Current Ratio was at its highest in in the March 2024 quarter at 57.95. The Current Ratio was at its lowest in in the March 2023 quarter at 0.
Average
17.06
Median
11.70
Minimum
9.54
Maximum
35.30
Discovering the peaks and valleys of CG Oncology, Inc. Common stock Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 159.17%
Maximum Annual Current Ratio = 35.30
Minimum Annual Increase = -2.40%
Minimum Annual Current Ratio = 9.54
Year | Current Ratio | Change |
---|---|---|
2024 | 35.30 | 159.17% |
2023 | 13.62 | 42.74% |
2022 | 9.54 | -2.40% |
The current Current Ratio of CG Oncology, Inc. Common stock (CGON) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
19.49
5-year avg
17.06
10-year avg
17.06
CG Oncology, Inc. Common stock’s Current Ratio is
Company | Current Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CG Oncology, Inc. Common stock using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CG Oncology, Inc. Common stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is CG Oncology, Inc. Common stock's Current Ratio?
How is the Current Ratio calculated for CG Oncology, Inc. Common stock (CGON)?
What is the highest Current Ratio for CG Oncology, Inc. Common stock (CGON)?
What is the 3-year average Current Ratio for CG Oncology, Inc. Common stock (CGON)?
What is the 5-year average Current Ratio for CG Oncology, Inc. Common stock (CGON)?
How does the current Current Ratio for CG Oncology, Inc. Common stock (CGON) compare to its historical average?